Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells

Area of Science:

• Molecular Biology
• Stem Cell Biology
• Genetic Engineering

Background:

• Synthetic oligodeoxynucleotides (ODNs) are explored for gene modification to address genetic disorders.
• Mesenchymal stem cells (MSCs) are a potential cell-based therapy for genetic diseases.

Purpose of the Study:

• To evaluate the efficacy of ODN-mediated gene repair in bone marrow-derived MSCs.
• To establish and characterize MSC cell lines for gene repair studies.

Main Methods:

• Created MSC cell lines with integrated mutant reporter genes (neomycin resistance and GFP).
• Transfected MSCs with gene-specific ODNs to correct targeted mutations.
• Confirmed gene correction via DNA sequencing and assessed protein expression.

Main Results:

• ODN transfection achieved gene repair in MSCs at a frequency of approximately 0.2%.
• Corrected cells expressed functional proteins, with repair efficiency influenced by nucleotide mismatch position.
• Genetically corrected MSCs remained healthy, undifferentiated, and capable of engrafting into various tissues.

Conclusions:

• ODN-mediated gene repair is feasible and effective in MSCs.
• Corrected MSCs are a promising therapeutic tool for a broad spectrum of clinical applications in genetic disorders.